Plant Construction & Process Technology

The Lean Revolution

11.04.2013 - Plant Design and Construction - Lean Manufacturing principles have transformed product quality, efficiency and business agility in the volume manufacturing sectors such as the...

Plant Construction & Process Technology

Insight into the Cosmeceutical Market

11.04.2013 - The global population grows older while increasing social pressures drive individuals to look younger. Consumer awareness has risen for cosmeceutical products which offer a way to...

Plant Construction & Process Technology

Developments of Drug Delivery Devices are Increasingly Focused on Patients’ Needs

11.04.2013 - Delivery Boom - Drug Delivery Devices currently rank among the major pharmaceutical trends. Their optimization is largely influenced by the pharmaceutical industry, physicians and...

Plant Construction & Process Technology

Plant Information Management: The Key Differentiator

21.11.2012 - These are troubling times for executives determining strategies and tactics for their organizations. Gone are the safe, traditionally competitive, resourceful, and technological...

Plant Construction & Process Technology

A Price Tag of 1.2 Billion Euros

21.11.2012 - Mega Project - As the world's population rises, there is a growing demand for fertilizers. Huge energy reserves, such as petroleum and natural gas deposits, are an ideal basis for...

Plant Construction & Process Technology

Biosimilars on Their Way into Global Biopharmaceuticals Market

20.11.2012 - With an introduction to the U.S. set for 2014, and the realization of massive potential in the emerging markets of Asia, biosimilars are set to take a sizable chunk of the global...

Plant Construction & Process Technology

Pharma vs. the World

20.11.2012 - In A Clinch - Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient advocacy groups, investors, physicians and even other...

Plant Construction & Process Technology

Orphan Drugs

20.11.2012 - New Markets - An estimated 25 million people in the U.S. suffer from rare diseases, known in the pharmaceutical industry as "orphan diseases". While the prevalence of each...